As the House Energy and Commerce Committee prepares to craft comprehensive legislation to address the nation’s opioid epidemic, AHA today urged the committee to report legislation to align 42 CFR Part 2 with the Health Insurance Portability and Accountability Act. “Congress must amend this law, which impedes the sharing of critical patient information that is necessary to deliver the most effective and efficient care,” AHA Executive Vice President Tom Nickels said in a letter to committee leaders. “Applying the same requirements to all patient information − whether behavioral or medical − would support the appropriate information sharing essential for clinical care coordination and population health improvement, while safeguarding patient information from unwarranted disclosure. H.R. 3545 would achieve these goals and we, therefore, urge the Committee to report this important legislation as introduced.” Tomorrow afternoon, the committee will convene a two-day hearing on more than 30 bills to address the opioid crisis through Medicare and Medicaid coverage and payment policies.
 

Related News Articles

Headline
The Medicare Payment Advisory Commission March 15 released its March report to Congress, which includes its recent recommendations for hospital and other…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Blog
The Medicare Payment Advisory Commission (MedPAC) today released its annual March Report advising Congress on the Medicare fee-for-service (FFS) payment…
Headline
The House Energy and Commerce Committee March 12 passed AHA-supported  legislation to reauthorize through 2029 the Dr. Lorna Breen Health Care Provider…
Headline
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…